And the other study, a comparative analysis, showed that delgocitinib's efficacy was "comparable to the biologic dupilumab specifically for the treatment of atopic hand eczema," said Chovatiya ...
Researchers investigated patient knowledge and fears concerning topical corticosteroid use for chronic hand eczema and how patient beliefs impacted treatment adherence.
Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.
Lead Study Author, Year No. of Patients with Population Characteristics Ages (yr) AD Diagnostic Criteria Hand Eczema Pattern Cronin, 1985 263 with HE only and history of AD Not specified Patient ...